中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
1期
103-104
,共2页
钟慕仪%叶艳娜%吴丽华%张蓉%张爱玲
鐘慕儀%葉豔娜%吳麗華%張蓉%張愛玲
종모의%협염나%오려화%장용%장애령
美兰%乳腺癌%前哨淋巴结
美蘭%乳腺癌%前哨淋巴結
미란%유선암%전초림파결
Methylene blue%Breast cancer%Sentinel lymph node
目的:探讨美兰染色在乳腺癌前哨淋巴结活检术中的临床应用及准确性分析.方法:选择笔者所在医院2007-2012年72例乳腺癌患者,体查均未扪及腋窝肿大淋巴结,在确诊后于乳晕周或病灶周取4个点皮下注射美兰,定位前哨淋巴结,行前哨淋巴结活检并清扫腋窝淋巴结.结果:72例患者中检出前哨淋巴结70例(检出率97.2%),前哨淋巴结阳性31例(44.2%),其中,其余腋窝淋巴结阳性为15例,阴性16例;前哨淋巴结阴性39例(55.7%),其中其余腋窝淋巴结为阳性的3例,阴性的36例.结论:美兰染色在乳腺癌前哨淋巴结中的应用具有敏感性和准确性,可以预测腋窝淋巴结的转移状态.
目的:探討美蘭染色在乳腺癌前哨淋巴結活檢術中的臨床應用及準確性分析.方法:選擇筆者所在醫院2007-2012年72例乳腺癌患者,體查均未捫及腋窩腫大淋巴結,在確診後于乳暈週或病竈週取4箇點皮下註射美蘭,定位前哨淋巴結,行前哨淋巴結活檢併清掃腋窩淋巴結.結果:72例患者中檢齣前哨淋巴結70例(檢齣率97.2%),前哨淋巴結暘性31例(44.2%),其中,其餘腋窩淋巴結暘性為15例,陰性16例;前哨淋巴結陰性39例(55.7%),其中其餘腋窩淋巴結為暘性的3例,陰性的36例.結論:美蘭染色在乳腺癌前哨淋巴結中的應用具有敏感性和準確性,可以預測腋窩淋巴結的轉移狀態.
목적:탐토미란염색재유선암전초림파결활검술중적림상응용급준학성분석.방법:선택필자소재의원2007-2012년72례유선암환자,체사균미문급액와종대림파결,재학진후우유훈주혹병조주취4개점피하주사미란,정위전초림파결,행전초림파결활검병청소액와림파결.결과:72례환자중검출전초림파결70례(검출솔97.2%),전초림파결양성31례(44.2%),기중,기여액와림파결양성위15례,음성16례;전초림파결음성39례(55.7%),기중기여액와림파결위양성적3례,음성적36례.결론:미란염색재유선암전초림파결중적응용구유민감성화준학성,가이예측액와림파결적전이상태.
Objective:To evaluate the efficacy of sentinel lymph node biopsy(SLNB)by using methylene blue in the management of breast cancer. Method:From 2007-2012,totally 72 patients with breast cancer in our hospital,physical examination of no palpable lymph nodes,received subareolar or under the skin injection of methylene blue for SLNB,and then axillary lymph node dissection.Result:The SLNB was completed successfully in 70 of the patients(97.2%),in the 70 cases who received SLNB,SLN metastasis was found in 31 cases,;and not found in 39 cases.Conclusion:The metastasis to the axillary lymph nodes can be found earlier by sentinel lymph node biopsy.